DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T. Lucier Purchases 15,142 Shares

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $16.15 on Thursday. DENTSPLY SIRONA Inc. has a 1-year low of $15.47 and a 1-year high of $34.28. The firm has a market cap of $3.21 billion, a PE ratio of -7.80, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The stock has a 50-day moving average price of $18.71 and a 200-day moving average price of $21.32. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.96%. DENTSPLY SIRONA’s payout ratio is presently -14.07%.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on XRAY. Evercore ISI reissued an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Barrington Research decreased their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Finally, Robert W. Baird dropped their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $23.58.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors have recently bought and sold shares of the company. Riverview Trust Co bought a new position in DENTSPLY SIRONA in the fourth quarter valued at $26,000. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. Capital Performance Advisors LLP purchased a new stake in DENTSPLY SIRONA during the 3rd quarter valued at $27,000. MassMutual Private Wealth & Trust FSB grew its position in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the period. Finally, UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 564 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.